Navigation Links
Cystic Fibrosis Foundation Named Charitable Organization of the Year by USA Track & Field
Date:10/29/2007

BETHESDA, Md., Oct. 29 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation was selected today as the 2006 Charitable Organization of the Year by USA Track & Field (USATF), the national governing body of track and field, long-distance running and race walking.

The CF Foundation was honored for its largest fundraising program -- GREAT STRIDES -- a national walk that raised nearly $32 million in 2006, and for other road races, jogs and marathons that raise money to support vital CF research and care programs.

"The Cystic Fibrosis Foundation has established one of the country's most successful fund-raising programs by speaking to Americans' desire to do something - not simply donate money - for a cause," said USATF CEO Craig A. Masback. "Runners and walkers join forces around the country to help fight a fatal disease. The fundraising of GREAT STRIDES has played a direct role in positively affecting lives."

As part of GREAT STRIDES, more than 200,000 coworkers, friends and family come together each year to walk in support of one cause: a cure for CF. GREAT STRIDES features nearly 600 walk sites, with participants walking as individuals or teams to raise money for CF. Since the first GREAT STRIDES walk in 1989, approximately $250 million has been raised.

"We are grateful to the tens of thousands of GREAT STRIDES walkers who come together in their individual communities to make a difference in the lives of people with cystic fibrosis," said Robert J. Beall, Ph.D., president and CEO of the Cystic Fibrosis Foundation. "The CF Foundation is honored to be named Charitable Organization of the Year by USA Track and Field and to be recognized for the important role we play in fighting this devastating disease. In fact, since GREAT STRIDES began 19 years ago, the median age of survival for people with CF has increased by 10 years to 37 years old."

Since 2002, USA Track & Field (USATF) has studied the impact of charitable walking and running in the U. S. The annual award, based on USATF's studies, recognizes charitable organizations like the CF Foundation that have successfully advanced their cause through walks and runs. Including GREAT STRIDES contributions, more than $714 million was raised for charity by runners and walkers in 2007, USATF's study found. Cystic fibrosis is a life-threatening, genetic disease that affects about 30,000 children and adults in the United States.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation funds CF research, has 80 chapter and branch offices throughout the country, and supports and accredits a nationwide network of 115 CF care centers, which provide vital treatments and other CF resources to patients and families. Nearly 90 cents of every dollar raised by the CF Foundation is available to fund CF research and care programs. For more information, visit http://www.cff.org.

To help fight CF, get involved in GREAT STRIDES by calling (800) FIGHT CF or visiting http://greatstrides.cff.org/.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Gene Therapy For Cystic Fibrosis
2. Antiparasitic Drug Effective In Reducing Seizures In Neurocysticercosis Patients
3. Surprising Cystic Fibrosis Finding That Could Be A Helpful Treatment Option
4. The Use Of Colistin To Treat Cystic Fibrosis Questioned
5. Approval for DNA test to detect cystic fibrosis
6. Cystic fibrosis patients may require a new treatment for bacterial infection
7. Developmental Origins of Polycystic Ovarian Syndrome
8. Roots of polycystic ovarian syndrome traced to mother’s wom
9. Polycystic Ovarian Syndrome(PCOS) linked to Diabetes
10. Treatment for Cystic Fibrosis in the future
11. Polycystic Ovary In Women May Raise Liver Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest ... . , Millions of individuals in the United States and Canada wear eyeglasses. Once ... to both correct vision and make a fashion statement. Even celebrities use glasses as ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: